glp-1 news oct 16 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 in three charts: sticky
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Roseberry A.G
And we are joined by Dr
doi: 10.1111/dom.14198 122 YangG-RZhaoX-LJinFShiL-HYangJ-K
Even short-term changes in treatment may have meaningful implications for patients as they navigate the impact of formulary decisions
Changes in Coagulation Factors Semaglutide, the active ingredient in Ozempic, may indirectly influence coagulation pathways
